Last reviewed · How we verify
Concomitant administration of EV71vaccine with EPI vaccines
Concomitant administration of EV71vaccine with EPI vaccines is a Biologic drug developed by Sinovac Biotech Co., Ltd. It is currently FDA-approved.
At a glance
| Generic name | Concomitant administration of EV71vaccine with EPI vaccines |
|---|---|
| Sponsor | Sinovac Biotech Co., Ltd |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Concomitant administration of EV71vaccine with EPI vaccines CI brief — competitive landscape report
- Concomitant administration of EV71vaccine with EPI vaccines updates RSS · CI watch RSS
- Sinovac Biotech Co., Ltd portfolio CI
Frequently asked questions about Concomitant administration of EV71vaccine with EPI vaccines
What is Concomitant administration of EV71vaccine with EPI vaccines?
Concomitant administration of EV71vaccine with EPI vaccines is a Biologic drug developed by Sinovac Biotech Co., Ltd.
Who makes Concomitant administration of EV71vaccine with EPI vaccines?
Concomitant administration of EV71vaccine with EPI vaccines is developed and marketed by Sinovac Biotech Co., Ltd (see full Sinovac Biotech Co., Ltd pipeline at /company/sinovac-biotech-co-ltd).
What development phase is Concomitant administration of EV71vaccine with EPI vaccines in?
Concomitant administration of EV71vaccine with EPI vaccines is FDA-approved (marketed).